PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $98.50 Consensus Target Price from Analysts
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has been given a consensus rating of “Moderate Buy” by the fifteen brokerages that are currently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, ten have assigned a buy rating and one […]
20 Sep 03:30 · The Cerbat Gem